Theravance Biopharma (TBPH) Reports Expanded COPD Indication for Trelegy Ellipta in Europe
Tweet Send to a Friend
Theravance Biopharma, Inc. (NASDAQ: TBPH) today highlighted that the European Commission authorized an expanded label for once-daily Trelegy Ellipta (fluticasone ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
